Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End-use (Medical Use, Recreational Use, Industrial Use), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Source
                        1.1.2. Derivative
                        1.1.3. End-use
                        1.1.4. Estimates and forecast timeline.
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database.
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                        1.6.2. Approach 1: Commodity flow approach
                        1.6.3. Volume price analysis (Model 2)
                        1.6.4. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Source outlook
                        2.2.2. Derivative outlook
                        2.2.3. End-use outlook
                    2.3. Competitive Insights
Chapter 3. Australia Legal Cannabis Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. Australia Legal Cannabis Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                        3.3.3. Regulatory Scenario
                        3.3.4. Case Study Analysis
Chapter 4. Australia Legal Cannabis Market: Source Estimates & Trend Analysis
                    4.1. Source Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Australia Legal Cannabis Market by Source Outlook
                    4.4. Marijuana
                        4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        4.4.2. Flower
                            4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        4.4.3. Oil and Tinctures
                            4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    4.5. Hemp
                        4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.2. Hemp CBD
                            4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.3. Supplements
                            4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.4. Industrial Hemp
                            4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Australia Legal Cannabis Market: Derivative Estimates & Trend Analysis
                    5.1. Derivative Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Australia Legal Cannabis Market by Derivative Outlook
                    5.4. CBD
                        5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    5.5. THC
                        5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    5.6. Others
                        5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Australia Legal Cannabis Market: End-use Estimates & Trend Analysis
                    6.1. End-use Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. Global Australia Legal Cannabis Market by End-use Outlook
                    6.4. Medical
                        6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.2. Cancer
                            6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.3. Chronic Pain
                            6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.4. Depression and Anxiety
                            6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.5. Arthritis
                            6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.6. Diabetes
                            6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.7. Glaucoma
                            6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.8. Migraines
                            6.4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.9. Epilepsy
                            6.4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.10. Multiple Sclerosis
                            6.4.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.11. AIDS
                            6.4.11.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.12. Amyotrophic Lateral Sclerosis
                            6.4.12.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.13. Alzheimer’s Disease
                            6.4.13.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.14. Post-traumatic Stress Disorder (PTSD)
                            6.4.14.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.15. Parkinson's Disease
                            6.4.15.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.16. Tourette Syndrome
                            6.4.16.1. Market estimates and forecast 2018 to 2030 (USD Million)
                        6.4.17. Others
                            6.4.17.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    6.5. Recreational
                        6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    6.6. Industrial
                        6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Company Market Position Analysis
                    7.4. Company Profiles
                        7.4.1. Cann Group Limited
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Zelira Therapeutics
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. AusCann Group Holdings Ltd.
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Bod Australia
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Althea Group
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. ECOFIBRE
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. Botanix Pharmaceuticals
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. EPSILON
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. Little Green Pharma
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives
                        7.4.10. Incannex
                            7.4.10.1. Company overview
                            7.4.10.2. Financial performance
                            7.4.10.3. Product benchmarking
                            7.4.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Australia legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Australia legal cannabis market, by derivative, 2018 - 2030 (USD Million)
Table 5 Australia legal cannabis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Australia legal cannabis market: market outlook
Fig. 9 Australia legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Australia legal cannabis market driver impact
Fig. 15 Australia legal cannabis market restraint impact
Fig. 16 Australia legal cannabis market: Source movement analysis
Fig. 17 Australia legal cannabis market: Source outlook and key takeaways
Fig. 18 Marijuana market estimates and forecast, 2018 - 2030
Fig. 19 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Oil & tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Hemp market estimates and forecast, 2018 - 2030
Fig. 22 Hemp CBD market estimates and forecast, 2018 - 2030
Fig. 23 Supplements market estimates and forecast, 2018 - 2030
Fig. 24 Industrial hemp market estimates and forecast, 2018 - 2030
Fig. 25 Australia legal cannabis market: Derivative movement analysis
Fig. 26 Australia legal cannabis market: Derivative outlook and key takeaways
Fig. 27 CBD market estimates and forecast, 2018 - 2030
Fig. 28 THC market estimates and forecast, 2018 - 2030
Fig. 29 Others market estimates and forecast, 2018 - 2030
Fig. 30 Australia legal cannabis market: Derivative movement analysis
Fig. 31 Australia legal cannabis market: Derivative outlook and key takeaways
Fig. 32 Medical market estimates and forecast, 2018 - 2030
Fig. 33 Cancer market estimates and forecast, 2018 - 2030
Fig. 34 Chronic Pain market estimates and forecast, 2018 - 2030
Fig. 35 Depression and Anxiety market estimates and forecast, 2018 - 2030
Fig. 36 Arthritis market estimates and forecast, 2018 - 2030
Fig. 37 Diabetes market estimates and forecast, 2018 - 2030
Fig. 38 Glaucoma market estimates and forecast, 2018 - 2030
Fig. 39 Migraines market estimates and forecast, 2018 - 2030
Fig. 40 Epilepsy market estimates and forecast, 2018 - 2030
Fig. 41 Multiple Sclerosis market estimates and forecast, 2018 - 2030
Fig. 42 AIDS market estimates and forecast, 2018 - 2030
Fig. 43 Amyotrophic Lateral Sclerosis market estimates and forecast, 2018 - 2030
Fig. 44 Alzheimer’s Disease market estimates and forecast, 2018 - 2030
Fig. 45 Post-traumatic Stress Disorder (PTSD) market estimates and forecast, 2018 - 2030
Fig. 46 Parkinson's Disease market estimates and forecast, 2018 - 2030
Fig. 47 Tourette Syndrome market estimates and forecast, 2018 - 2030
Fig. 48 Others market estimates and forecast, 2018 - 2030
Fig. 49 Recreational market estimates and forecast, 2018 - 2030
Fig. 50 Industrial market estimates and forecast, 2018 - 2030
Fig. 51 Market share of key market players- Australia legal cannabis market